date name shares transaction value  kenneth s robinson director    award at  per share   garry arthur neil director    award at  per share   kenneth s robinson director    award at  per share   garry arthur neil director    award at  per share   kenneth s robinson director    award at  per share   garry arthur neil director    award at  per share   diane c young vp chief medical officer    disposition at  per share   marc steven hanover chief executive officer director    award at  per share   robert james wills executive chairman director    award at  per share   the pyramid peak foundation    acquisition at  per share   kenneth s robinson director    award at  per share   garry arthur neil director    award at  per share   garry arthur neil director    award at  per share   kenneth s robinson director    award at  per share   robert james wills executive chairman director    acquisition at  per share   kenneth s robinson director    award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals transaction summary total insider purchases and sales reported to the sec timeframe transactions shares last  months  purchases  sales   last  months  purchases  sales   last  months  purchases  sales   officers and executives dr robert james wills executive chairman mr marc steven hanover chief executive officer  director mr jason t shackelford principal financial  accounting officer dr diane c young chief medical officer  vice president dr mary ann johnston vpmedical affairs  clinical operations mr jeffrey g hesselberg vice presidentregulatory affairs mr henry patton doggrell secretary chief legal officer  vice president mr joseph r hyde lead independent director dr garry arthur neil independent director dr michael g carter independent director dr kenneth s robinson independent director mr j kenneth glass independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pif you suddenly quit your job like sean spicer here’s what you should do next pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders pbanks have raised creditcard interest rates — but not savings account rates aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  gtxi historical stock quotes  gtx inc historical stock quotes  marketwatch bulletin investor alert tokyo markets close in currencies europe markets london markets expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close gtx inc nasdaq gtxi go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus gtx inc market closed  quotes are delayed by  min jul    pm gtxi quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   enter date historical quote for gtxi friday july   closing price open high low volume  unadjusted price  adjustment factor trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pif you suddenly quit your job like sean spicer here’s what you should do next pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders pbanks have raised creditcard interest rates — but not savings account rates aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  gtxi sec filings  gtx inc sec filings  marketwatch bulletin investor alert tokyo markets close in currencies europe markets london markets expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close gtx inc nasdaq gtxi go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus gtx inc market closed  quotes are delayed by  min jul    pm gtxi quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   show all k k q proxy registration d f g sec filings for gtx inc getting started with sec filings filing date document date type category amended   k special events   q quarterly reports   k special events   k special events   k special events   def a proxy statement   k annual reports   k special events  na sc ga institutional ownership   na sc ga institutional ownership    k special events   k special events   k special events   k special events  na sc ga institutional ownership    k special events   k special events   q quarterly reports   k special events  na sc da na  more sec filings provided by edgar online inc trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite tlt quoteszigmancomposite jnug x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pif you suddenly quit your job like sean spicer here’s what you should do next pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders pbanks have raised creditcard interest rates — but not savings account rates aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  pipeline  gtx   information request contact careers search search pipelineoverview stress urinary incontinence breast cancer duchenne muscular dystrophy prostate cancer pipelinenovember  dan cowpernovember   developing oral medicines based on hormone receptor targeting for patients in need indication study number drug preclinical phase  phase  phase  stress urinary incontinence g enobosarm sarm  breast cancer er  ar g enobosarm sarm completed er  ar g enobosarm sarm  ar tnbc g enobosarm sarm  duchenne muscular dystrophy preclinical candidate sarm  prostate cancer preclinical candidate sard  indication study number drug phase stress urinary incontinence g enobosarm sarm ph breast cancer er  ar g enobosarm sarm ph er  ar g enobosarm sarm ph ar tnbc g enobosarm sarm ph duchenne muscular dystrophy preclinical candidate sarm preclin prostate cancer preclinical candidate sard preclin menu about overview management team board of directors careers contact pipeline overview stress urinary incontinence breast cancer duchenne muscular dystrophy prostate cancer diseases overview stress urinary incontinence breast cancer duchenne muscular dystrophy prostate cancer science overview selective androgen receptor modulator sarm the potential advantage of sarms sarms in breast cancer sarms in muscle diseases sarms in urology selective androgen receptor degrader sard investors overview news releases events  presentations financial reports sec filings stock information historic stock lookup investment calculator analyst coverage corporate governance management board of directors committee composition investor faqs irs form  contact us gtx inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies  pharma info market research report gtx inc  product pipeline review   published by global markets direct product code  published may   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license gtx inc  product pipeline review   published may   content info  pages description summary global markets directs gtx inc  product pipeline review   provides an overview of the gtx incs pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by gtx inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope the report provides a snapshot of the pipeline therapeutic landscape of gtx inc the report provides overview of gtx inc including its business description key facts and locations and subsidiaries the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages the report assesses gtx incs pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type the report features gtx incs outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy evaluate gtx incs strategic position with total access to detailed information on its product pipeline gain strategically significant competitor information analysis and insights to formulate effective rd strategies identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage identify and understand important and diverse types of therapeutics under development for gtx inc identify potential new clients or partners in the target demographic plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics devise corrective measures for pipeline projects by understanding gtx incs pipeline depth and focus of pipeline therapeutics develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures gtx inc snapshot gtx inc overview key information key facts gtx inc  research and development overview key therapeutic areas gtx inc  pipeline review pipeline products by stage of development pipeline products  monotherapy gtx inc  pipeline products glance gtx inc  clinical stage pipeline products phase ii productscombination treatment modalities gtx inc  early stage pipeline products preclinical productscombination treatment modalities gtx inc  drug profiles enobosarm product description mechanism of action rd progress gtx product description mechanism of action rd progress betalgnd product description mechanism of action rd progress gtx product description mechanism of action rd progress gtx product description mechanism of action rd progress gtx product description mechanism of action rd progress gtx product description mechanism of action rd progress gtx product description mechanism of action rd progress small molecules to antagonize androgen receptor for metastatic castration resistant prostate cancer product description mechanism of action rd progress small molecules to inhibit akrc for prostate cancer and castration resistant prostate cancer product description mechanism of action rd progress small molecules to inhibit tubulin for cancer product description mechanism of action rd progress gtx inc  pipeline analysis gtx inc  pipeline products by target gtx inc  pipeline products by route of administration gtx inc  pipeline products by molecule type gtx inc  pipeline products by mechanism of action gtx inc  recent pipeline updates gtx inc  dormant projects gtx inc  discontinued pipeline products discontinued pipeline product profiles toremifene citrate gtx inc  company statement gtx inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables gtx inc key information gtx inc key facts gtx inc  pipeline by indication  gtx inc  pipeline by stage of development  gtx inc  monotherapy products in pipeline  gtx inc  phase ii  gtx inc  preclinical  gtx inc  pipeline by target  gtx inc  pipeline by route of administration  gtx inc  pipeline by molecule type  gtx inc  pipeline products by mechanism of action  gtx inc  recent pipeline updates  gtx inc  dormant developmental projects gtx inc  discontinued pipeline products  list of figures gtx inc  pipeline by top  indication  gtx inc  pipeline by stage of development  gtx inc  monotherapy products in pipeline  gtx inc  pipeline by target  gtx inc  pipeline by route of administration  gtx inc  pipeline by molecule type  gtx inc  pipeline products by mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved gtx inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports gtx inc  product pipeline review   gtx inc  product pipeline review   wgr  april  global  pages global markets direct description table of content sample report enquiry before buy related reports gtx inc  product pipeline review  summaryglobal markets direct’s ‘gtx inc  product pipeline review  ’ provides an overview of the gtx inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of gtx inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of gtx inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of gtx inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the gtx inc’s pipeline productsreasons to buy evaluate gtx inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of gtx inc in its therapy areas of focus identify new drug targets and therapeutic classes in the gtx inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of gtx inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of gtx inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of gtx inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures gtx inc snapshot gtx inc overview key information key facts gtx inc  research and development overview key therapeutic areas gtx inc  pipeline review pipeline products by stage of development pipeline products  monotherapy gtx inc  pipeline products glance gtx inc  late stage pipeline products phase iii productscombination treatment modalities gtx inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities gtx inc  early stage pipeline products preclinical productscombination treatment modalities gtx inc  drug profiles enobosarm product description mechanism of action rd progress gtx product description mechanism of action rd progress gtx product description mechanism of action rd progress betalgnd product description mechanism of action rd progress gtx product description mechanism of action rd progress gtx product description mechanism of action rd progress small molecule to inhibit akrc for prostate cancer product description mechanism of action rd progress small molecule to inhibit tubulin for cancer product description mechanism of action rd progress gtx inc  pipeline analysis gtx inc  pipeline products by target gtx inc  pipeline products by route of administration gtx inc  pipeline products by molecule type gtx inc  pipeline products by mechanism of action gtx inc  recent pipeline updates gtx inc  dormant projects gtx inc  discontinued pipeline products discontinued pipeline product profiles gtx toremifene citrate gtx inc  company statement gtx inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesgtx inc key information gtx inc key facts gtx inc  pipeline by indication  gtx inc  pipeline by stage of development  gtx inc  monotherapy products in pipeline  gtx inc  phase iii  gtx inc  phase ii  gtx inc  phase i  gtx inc  preclinical  gtx inc  pipeline by target  gtx inc  pipeline by route of administration  gtx inc  pipeline by molecule type  gtx inc  pipeline products by mechanism of action  gtx inc  recent pipeline updates  gtx inc  dormant developmental projects gtx inc  discontinued pipeline products  list of figuresgtx inc  pipeline by top  indication  gtx inc  pipeline by stage of development  gtx inc  monotherapy products in pipeline  gtx inc  pipeline by top  target  gtx inc  pipeline by top  route of administration  gtx inc  pipeline by top  molecule type  gtx inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send gtxi news  gtx inc company news  press releases  marketwatch bulletin investor alert tokyo markets close in currencies europe markets london markets expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close gtx inc nasdaq gtxi go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus gtx inc market closed  quotes are delayed by  min jul    pm gtxi quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   newslatestcompanyusgtxi marketwatch news on gtxi california doctors charged with insider trading after drug tests halted  pm may    russ britt tuesday’s biggest gaining and declining stocks  pm may    marketwatch gtx rallies  on fda update  pm may    val brickates kennedy gtx fda lifts hold on capesaris trials  am may    marketwatchcom gtx inc up  in premarket  am may    steve gelsi gtx responds to fda halt on capesaris trial  am april    marketwatchcom tuesday’s biggest gaining  declining stocks  pm feb    kate gibson gtx fda halts capesaris trials on bloodclot risk  am feb    marketwatchcom monday’s biggest gaining and declining stocks  pm jan    kate gibson gtx soars  on analyst upgrade reports  pm jan    val brickates kennedy gtx gains on analyst rating  pm july    val brickates kennedy carpenter molycorp office depot among gainers  am june    tom bemis ten gainers in wednesdays market  am june    craig tolliver wednesday’s biggest gaining and declining stocks  pm april    william spain drug stocks inch higher in afternoon trading  pm april    val brickates kennedy gtx rockets on analyst upgrade  am april    val brickates kennedy gtx falls in drugstock trading  pm march    val brickates kennedy amylin illumina gain drug indexes slip  am oct    val brickates kennedy wednesdays biggest gaining and declining stocks  pm may    marketwatch drug stocks rebound gtx sinks on failed study  am may    val brickates kennedy loading more headlines newsnonmarketwatchcompanyusgtxi other news on gtxi gtxs gtxi enobosarm positive in phase ii study shares up  am june    zackscom premarket gainers as of  am  am june    seeking alpha gtxs enobosarm shows treatment effect in midstage study in postmenopausal women with stress urinary incontinence shares up  premarket  am june    seeking alpha hottest manufacturing stocks now – neon tpiv gtxi bmra  pm dec    investorplacecom hottest manufacturing stocks now – ebs aciu vcel opht  pm dec    investorplacecom gtxs enobosarm shows treatment benefit at  weeks in midstage breast cancer study  am dec    seeking alpha gtxs enobosarm successful in midstage breast cancer study shares up   am nov    seeking alpha gtx gtxi investor presentation  slideshow  pm nov    seeking alpha stage  milestone met in gtxs midstage study of lead product candidate in certain type of breast cancer trial to advance to stage   am nov    seeking alpha q gtx inc de  pm nov    edgar online  edg  q k insider invests in gtx  pm oct    gurufocuscom gtxs enobosarm shows positive results in midstage breast cancer study shares up   pm sept    seeking alpha q gtx inc de  pm aug    edgar online  edg  q k gtx gtxi shows strength stock adds  in session  am june    zackscom gtxs gtxi ceo marc hanover on q  results  earnings call transcript  am march    seeking alpha gtx reports q and fy results  am march    seeking alpha gtx gtxi q  results  earnings call webcast  am march    seeking alpha strength seen in gtx gtxi stock adds  in session  am dec    zackscom gtxs gtxi ceo marc hanover on q  results  earnings call transcript  am oct    seeking alpha gtx gtxi q  results  earnings call webcast  am oct    seeking alpha loading more headlines newspressreleasecompanyusgtxi press releases on gtxi gtx discusses key goals with wsa  pm july    marketwired pharma and biotech companies significantly investing in rd focus on rising demand for advanced medicines  am june    pr newswire  prf todays research reports on stocks to watch xbiotech and gtx  am june    accesswire gtx announces positive preliminary results from ongoing phase  proofofconcept clinical trial in women with stress urinary incontinence  am june    businesswire  bzx gtx provides corporate update and reports first quarter  financial results  am may    businesswire  bzx gtx announces acceptance of an abstract on preliminary results from phase  clinical trial in women with stress urinary incontinence at the international continence society annual meeting  am may    businesswire  bzx gtx announces results from preclinical studies of sarms in duchenne muscular dystrophy models published in human molecular genetics  am may    businesswire  bzx gtx provides corporate update and reports fourth quarter and yearend  financial results  am march    businesswire  bzx gtx inc to report fourth quarter and full year  financial results on march    am march    businesswire  bzx gtx reports results from ongoing enobosarm phase  clinical trial in erar breast cancer  am dec    businesswire  bzx gtx inc announces for reverse stock split  am dec    businesswire  bzx enobosarm meets prespecified primary efficacy endpoint in ongoing phase  clinical trial in erar breast cancer  am nov    businesswire  bzx gtx announces webcast of corporate presentation at the th annual piper jaffray healthcare conference  am nov    businesswire  bzx blog coverage gtx inc enobosarm achieves stage  milestone  am nov    accesswire gtx achieves second stage  milestone in phase  clinical trial of enobosarm in erar breast cancer  am nov    businesswire  bzx gtx announces webcast of corporate presentation at the stifel  healthcare conference  am nov    businesswire  bzx gtx provides corporate update and reports third quarter  financial results  am nov    businesswire  bzx significant investor maintains vote against proposed merger of female health company with aspen park pharmaceuticals  am oct    accesswire gtx announces  million registered direct common stock offering  am oct    businesswire  bzx gtx achieves stage  milestone in phase  clinical trial of enobosarm in erar breast cancer  am sept    businesswire  bzx loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pif you suddenly quit your job like sean spicer here’s what you should do next pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders pbanks have raised creditcard interest rates — but not savings account rates aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  gtx inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports gtx inc  product pipeline review   gtx inc  product pipeline review   wgr  may  global  pages global markets direct description table of content sample report enquiry before buy related reports gtx inc  product pipeline review   summary global markets direct’s ‘gtx inc  product pipeline review  ’ provides an overview of the gtx inc’s pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by gtx inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope  the report provides a snapshot of the pipeline therapeutic landscape of gtx inc  the report provides overview of gtx inc including its business description key facts and locations and subsidiaries  the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities  the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages  the report assesses gtx inc’s pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type  the report features gtx inc’s outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy  evaluate gtx inc’s strategic position with total access to detailed information on its product pipeline  gain strategically significant competitor information analysis and insights to formulate effective rd strategies  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  identify and understand important and diverse types of therapeutics under development for gtx inc  identify potential new clients or partners in the target demographic  plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics  devise corrective measures for pipeline projects by understanding gtx inc’s pipeline depth and focus of pipeline therapeutics  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope table of contents table of contents  list of tables  list of figures  gtx inc snapshot  gtx inc overview  key information  key facts  gtx inc  research and development overview  key therapeutic areas  gtx inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  gtx inc  pipeline products glance  gtx inc  clinical stage pipeline products  phase ii productscombination treatment modalities  gtx inc  early stage pipeline products  preclinical productscombination treatment modalities  gtx inc  drug profiles  enobosarm  product description  mechanism of action  rd progress  gtx  product description  mechanism of action  rd progress  betalgnd  product description  mechanism of action  rd progress  gtx  product description  mechanism of action  rd progress  gtx  product description  mechanism of action  rd progress  gtx  product description  mechanism of action  rd progress  gtx  product description  mechanism of action  rd progress  gtx  product description  mechanism of action  rd progress  small molecules to antagonize androgen receptor for metastatic castration resistant prostate cancer  product description  mechanism of action  rd progress  small molecules to inhibit akrc for prostate cancer and castration resistant prostate cancer  product description  mechanism of action  rd progress  small molecules to inhibit tubulin for cancer  product description  mechanism of action  rd progress  gtx inc  pipeline analysis  gtx inc  pipeline products by target  gtx inc  pipeline products by route of administration  gtx inc  pipeline products by molecule type  gtx inc  pipeline products by mechanism of action  gtx inc  recent pipeline updates  gtx inc  dormant projects  gtx inc  discontinued pipeline products  discontinued pipeline product profiles  toremifene citrate  gtx inc  company statement  gtx inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables gtx inc key information  gtx inc key facts  gtx inc  pipeline by indication   gtx inc  pipeline by stage of development   gtx inc  monotherapy products in pipeline   gtx inc  phase ii   gtx inc  preclinical   gtx inc  pipeline by target   gtx inc  pipeline by route of administration   gtx inc  pipeline by molecule type   gtx inc  pipeline products by mechanism of action   gtx inc  recent pipeline updates   gtx inc  dormant developmental projects  gtx inc  discontinued pipeline products   list of figures gtx inc  pipeline by top  indication   gtx inc  pipeline by stage of development   gtx inc  monotherapy products in pipeline   gtx inc  pipeline by target   gtx inc  pipeline by route of administration   gtx inc  pipeline by molecule type   gtx inc  pipeline products by mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send gtx inc  product pipeline review    market research reports® inc skip to main content home faqs contact us become publisher blog  items  search form search this site search you are here home catalog pharma  healthcare company reports pharma  healthcare gtx inc  product pipeline review   gtx inc  product pipeline review   printer versionsend by email publication id gmd publication date  may   pages   publisher global markets direct countries  global  publication type   select single user license pdf site license pdf global license pdf  please choose the suitable license type from above more details are at given under tab report license types below add to cart why to buy from us globally trusted brand we help executives from fortune  firms to startups with their market research needs thus we can help you too  shop with confidence if you have any presales questions related to this report pelase let us know using the report enquiry form below this will help us provide you with answers so that you can purchase with confidence secure checkout you can shop confidently as your online payments are processed using pci dss compliant secure payment gateways on our website frequently asked questions if you wish to read about frequently asked questions by our customers please visit our faqs page tabsdescription gtx inc  product pipeline review   summary global markets direct’s ‘gtx inc  product pipeline review  ’ provides an overview of the gtx inc’s pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by gtx inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope  the report provides a snapshot of the pipeline therapeutic landscape of gtx inc  the report provides overview of gtx inc including its business description key facts and locations and subsidiaries  the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities  the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages  the report assesses gtx inc’s pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type  the report features gtx inc’s outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy  evaluate gtx inc’s strategic position with total access to detailed information on its product pipeline  gain strategically significant competitor information analysis and insights to formulate effective rd strategies  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  identify and understand important and diverse types of therapeutics under development for gtx inc  identify potential new clients or partners in the target demographic  plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics  devise corrective measures for pipeline projects by understanding gtx inc’s pipeline depth and focus of pipeline therapeutics  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope table of contents table of contents table of contents  list of tables  list of figures  gtx inc snapshot  gtx inc overview  key information  key facts  gtx inc  research and development overview  key therapeutic areas  gtx inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  gtx inc  pipeline products glance  gtx inc  clinical stage pipeline products  phase ii productscombination treatment modalities  gtx inc  early stage pipeline products  preclinical productscombination treatment modalities  gtx inc  drug profiles  enobosarm  product description  mechanism of action  rd progress  gtx  product description  mechanism of action  rd progress  betalgnd  product description  mechanism of action  rd progress  gtx  product description  mechanism of action  rd progress  gtx  product description  mechanism of action  rd progress  gtx  product description  mechanism of action  rd progress  gtx  product description  mechanism of action  rd progress  gtx  product description  mechanism of action  rd progress  small molecules to antagonize androgen receptor for metastatic castration resistant prostate cancer  product description  mechanism of action  rd progress  small molecules to inhibit akrc for prostate cancer and castration resistant prostate cancer  product description  mechanism of action  rd progress  small molecules to inhibit tubulin for cancer  product description  mechanism of action  rd progress  gtx inc  pipeline analysis  gtx inc  pipeline products by target  gtx inc  pipeline products by route of administration  gtx inc  pipeline products by molecule type  gtx inc  pipeline products by mechanism of action  gtx inc  recent pipeline updates  gtx inc  dormant projects  gtx inc  discontinued pipeline products  discontinued pipeline product profiles  toremifene citrate  gtx inc  company statement  gtx inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables gtx inc key information  gtx inc key facts  gtx inc  pipeline by indication   gtx inc  pipeline by stage of development   gtx inc  monotherapy products in pipeline   gtx inc  phase ii   gtx inc  preclinical   gtx inc  pipeline by target   gtx inc  pipeline by route of administration   gtx inc  pipeline by molecule type   gtx inc  pipeline products by mechanism of action   gtx inc  recent pipeline updates   gtx inc  dormant developmental projects  gtx inc  discontinued pipeline products   list of figures gtx inc  pipeline by top  indication   gtx inc  pipeline by stage of development   gtx inc  monotherapy products in pipeline   gtx inc  pipeline by target   gtx inc  pipeline by route of administration   gtx inc  pipeline by molecule type   gtx inc  pipeline products by mechanism of action   companies covered na report license types single user license pdf this license allows for use of a publication by one person this person may print out a single copy of the publication this person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher this person cannot share the publication or any information contained therein with any other person or persons unless a global license is purchased a single user license must be purchased for every person that wishes to use the publication within the same organization customers who infringe these license terms are liable for a global license fee   site license pdf this license allows for use of a publication by all users within one corporate location eg a regional office these users may print out a single copy of the publication these users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher these users cannot share the publication or any information contained therein with any other person or persons outside the corporate location for which the publication is purchased unless a global license is purchased a site user license must be purchased for every corporate location by an organization that wishes to use the publication within the same organization customers who infringe these license terms are liable for a global license fee   global license pdf this license allows for use of a publication by unlimited users within the purchasing organization eg all employees of a single company each of these people may use the publication on any computer and may print out the report but may not share the publication or any information contained therein with any other person or persons outside of the organization these employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher if applicable report enquiry do you have more questions related to this market research report after going through the description and table of contents we are here to help please use the form given below to let us know your questions related to this report kindly use your official email address and contact number to ensure speedy response first name  last name  company  email address  phone including international code  report title  your inquiry  captchathis question is for testing whether you are a human visitor and to prevent automated spam submissions math question      solve this simple math problem and enter the result eg for  enter  submit company reports pharma  healthcarepharma  healthcare please note that the report cover image shown above is for representation purpose only actual report cover may vary  single user license pdf market research reports® inc httpwwwmarketresearchreportscom related market research reports publication price siemens healthcare gmbh  medical equipment  deals and alliances profile summary  invacare corporation ivc  medical equipment  deals and alliances profile summary  opko health inc opk  medical equipment  deals and alliances profile summary  revision optics inc  medical equipment  deals and alliances profile summary  bioptix inc biop  medical equipment  deals and alliances profile summary  biolase inc biol  medical equipment  deals and alliances profile summary  cormatrix cardiovascular inc  medical equipment  deals and alliances profile summary  biotime inc btx  medical equipment  deals and alliances profile summary  medtronic plc mdt  medical equipment  deals and alliances profile summary  transmedics inc  medical equipment  deals and alliances profile summary  veracyte inc vcyt  medical equipment  deals and alliances profile summary  irhythm technologies inc irtc  medical equipment  deals and alliances profile summary  clients who trust us need tailor made market research solution we can help you with that too contact us about us at market research reports inc we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best ie take timecritical decisions we work with our associate global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs be it custom research or syndicated research reports contact us market research reports inc  coastal hwy lewes de  usa usa  india  marketresearchreports email protected user login username  password  create new account request new password log in latest blog posts investment opportunities in taiwan semiconductor chemical and consumer goods will lead the pack global investment opportunities in ports and terminals stay connected sign up to our newsletter email address  subscribe research industries home automotive banking  finance business  government chemicals computing  electronics consumer  retail energy  utilities food  beverages industry  manufacturing marketing  advertising media pharma  healthcare telecom transport travel  leisure our company about us publications by country faqs privacy policy terms  conditions  copyright  market research reports inc all rights reserved m market research reports and the m market research reports logo are registered trademarks of market research reports inc disclaimer market research reports inc has no affiliation to and is not associated with any other websites or organizations we offer syndicated research reports like country analysis swot analysis competitive intelligence industry reports company reports and market analysis  trends reports and custom market research from our website marketresearchreportscom only if you are looking for a market research solution for your research requirements please begin your search using the search box on top of this page or use our chat system to speak to our market research consultants or directly write to us gtx inc  product pipeline review   trends share size research report uscanada toll free home global markets direct pharmaceutical gtx inc  product pipeline review   gtx inc  product pipeline review   published by  global markets direct published date  jul  category  pharmaceutical no of pages   pages description table of content check discount gtx inc  product pipeline review  summaryglobal markets directs gtx inc  product pipeline review   provides an overview of the gtx incs pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of gtx incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of gtx inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of gtx incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the gtx incs pipeline productsreasons to buy evaluate gtx incs strategic position with total access to detailed information on its product pipeline assess the growth potential of gtx inc in its therapy areas of focus identify new drug targets and therapeutic classes in the gtx incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of gtx inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of gtx inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of gtx inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures gtx inc snapshot gtx inc overview key information key facts gtx inc  research and development overview key therapeutic areas gtx inc  pipeline review pipeline products by stage of development pipeline products  monotherapy gtx inc  pipeline products glance gtx inc  late stage pipeline products phase iii productscombination treatment modalities gtx inc  clinical stage pipeline products phase ii productscombination treatment modalities gtx inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities gtx inc  drug profiles enobosarm product description mechanism of action rd progress gtx product description mechanism of action rd progress betalgnd product description mechanism of action rd progress gtx product description mechanism of action rd progress gtx product description mechanism of action rd progress small molecule to inhibit tubulin for cancer product description mechanism of action rd progress small molecules to inhibit akrc for prostate cancer and castration resistant prostate cancer product description mechanism of action rd progress small molecules to antagonize androgen receptor for metastatic castration resistant prostate cancer product description mechanism of action rd progress gtx inc  pipeline analysis gtx inc  pipeline products by target gtx inc  pipeline products by route of administration gtx inc  pipeline products by molecule type gtx inc  pipeline products by mechanism of action gtx inc  recent pipeline updates gtx inc  dormant projects gtx inc  discontinued pipeline products discontinued pipeline product profiles toremifene citrate gtx inc  company statement gtx inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesgtx inc key information gtx inc key facts gtx inc  pipeline by indication  gtx inc  pipeline by stage of development  gtx inc  monotherapy products in pipeline  gtx inc  phase iii  gtx inc  phase ii  gtx inc  preclinical  gtx inc  discovery  gtx inc  pipeline by target  gtx inc  pipeline by route of administration  gtx inc  pipeline by molecule type  gtx inc  pipeline products by mechanism of action  gtx inc  recent pipeline updates  gtx inc  dormant developmental projects gtx inc  discontinued pipeline products  list of figuresgtx inc  pipeline by top  indication  gtx inc  pipeline by stage of development  gtx inc  monotherapy products in pipeline  gtx inc  pipeline by top  target  gtx inc  pipeline by top  route of administration  gtx inc  pipeline by top  molecule type  gtx inc  pipeline products by top  mechanism of action   make an enquiry before buying this report please fill the enquiry form below full name  your email  job title  company  phone no  pls affix country code message security code   choose license type  select user license single license user  multiple license user  do you wish to check sample of this report order a sample report have query on this report related news zinc prices to continue to shoot as hopes of output rise remain bleak shift to cloudbased products and services fares well for microsoft india remains leading provider of online labors in technology and software development sector flipkart’s phonepe ventures in india’s offline space india introduces first train powered by solar power research assistance we will be happy to help you find what you need please call us or write to us  uscanada toll free tel   email  salesresearchmozus